跳至主要内容
临床试验/NL-OMON34433
NL-OMON34433尚未招募不适用

Pharmacokinetics and Pharmacodynamics of Medication in Asphyxiated Newborns During Controlled Hypothermia PharmaCool National Multicenter Study. - PharmaCool National Multicenter Study.

Academisch Medisch Centrum0 个研究点目标入组 270 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
270

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 11(—)

入选标准

  • Any newborn :;1) with a gestational age > 36 weeks and a birth weight > 3 kg;
  • 2) with Apgar Score at 5 minutes postnatal < 5;
  • 3) with continued resuscitation at 10 minutes postnatally;
  • 4) with 1 hour postnatal bloodgas analysis with pH < 7.0 or base deficit > 16
  • 5) with clinical signs of moderate to severe encephalopathy (defined as a Thomson score of >7 or a Sarnat score of >1)
  • 6) who is undergoing neuroprotective treatment by controlled hypothermia < 6 hours postnatally.

排除标准

  • 1) congenital hepatic or renal pathology (as this makes interpretation of PKPD results impossible);
  • 2) without central venous line or arterial bloodstream access for blood sampling;
  • 3) without written parental consent to participate following informed consent interview.

研究者

相似试验